SYDNEY, Australia, March 03, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a developer of a world-class platform of radiopharmaceutical products for both ...
Aktis Oncology said it appointed Dr. Ken Herrmann to the Board of Directors. Dr. Herrmann specializes in nuclear medicine and has over a decade of experience in clinical investigation, the company ...
Dr. Herrmann went to Saint Louis University for undergraduate studies and medical school, graduating top of her class. She completed a fellowship at Harvard University in surgical nutrition, then ...
In this issue, Dr. Bhatt talks with Howard C. Herrmann, MD, professor of medicine at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, director of the interventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results